United States · Finance & Insurance · USD (Millions) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Cushman & Wakefield Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | 4.75% | 5.7% | 6.95% | 8.37% | 9.92% |
|---|---|---|---|---|---|
| ROA | 1.16% | 1.49% | 1.92% | 2.49% | 3.23% |
| Total Assets | $7,676.60M | $7,740.26M | $7,767.04M | $7,793.65M | $7,820.24M |
| Net Income | $88.20M | $114.66M | $149.06M | $193.78M | $251.91M |
| Valuation | $70,196.17M | $91,255.02M | $118,631.52M | $154,220.98M | $200,487.27M |
| Stock Price | $11.84 | $15.39 | $20.01 | $26.01 | $33.82 |